3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular LymphomaDisease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 32026-10-08NCT04712097
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid TumorsNeoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorderActive, not recruitingPhase 1 / Phase 22026-08-21NCT05593094
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)Frailty, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cancer, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, depressive disorder, heart disorder, neoplasm, nervous system disorder, psychiatric disorder, stroke disorder, vascular disorderActive, not recruitingNot stated2025-11-04NCT07224347